RONALD DOAN: Open Payments
NPI 1710062864 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 25 payments from 5 companies in 2025. Trend: 2023 $906 · 2024 $1,706 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $595 |
| AstraZeneca Pharmaceuticals LP | 1 | $103 |
| Novo Nordisk Inc | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: QULIPTA, BREZTRI, Wegovy, UBRELVY, SHINGRIX, TRELEGY ELLIPTA, GARDASIL 9, VRAYLAR.
Industry payments across MI — which companies pay providers there.
